Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Rotavirus VP4 protein, commonly known as the P protein (protease-sensitive), is a key structural component of the rotavirus outer capsid that functions as a viral spike [1, 3]. It is essential for the virus's life cycle, mediating the initial attachment to host cell receptors and subsequent penetration of the cell membrane [3, 4]. For the virus to become infectious, VP4 must undergo proteolytic cleavage by intestinal enzymes into two subunits, VP5* and VP8* [1, 4]. In vaccine development, "P reassortants" are created by combining the VP4 gene from a human rotavirus strain with a bovine rotavirus backbone, a strategy used in the RotaTeq vaccine to provide immunity against common human P genotypes like P[8] [2]. By presenting this specific protein to the immune system, the vaccine induces the production of neutralizing antibodies that prevent the virus from entering host cells, thereby protecting against severe gastroenteritis [2, 3]. This reassortment technique allows for the creation of a live-attenuated virus that expresses human-specific antigens while maintaining the attenuated characteristics of the bovine parent strain [2]. The VP4 protein is a major determinant of viral host range and tissue tropism, making it a primary target for neutralizing immunity [3, 4]. Consequently, monitoring the genetic diversity of the VP4 gene is crucial for assessing vaccine efficacy against emerging rotavirus strains [3].
Induction of neutralizing antibodies that target the VP4 spike protein to inhibit viral attachment and entry into host enterocytes [2, 3].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rotavirus VP4 protein (VP4) (VP4).